ArticleClinical pharmacokinetics2010

A quantitative framework and strategies for management and evaluation of metabolic drug-drug interactions in oncology drug development: new molecular entities as object drugs.

Karthik Venkatakrishnan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.